These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 28389174

  • 1. A biotin-drug extraction and acid dissociation (BEAD) procedure to eliminate matrix and drug interference in a protein complex anti-drug antibody (ADA) isotype specific assay.
    Niu H, Klem T, Yang J, Qiu Y, Pan L.
    J Immunol Methods; 2017 Jul; 446():30-36. PubMed ID: 28389174
    [Abstract] [Full Text] [Related]

  • 2. Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays.
    Xu W, Jiang H, Titsch C, Haulenbeek JR, Pillutla RC, Aubry AF, DeSilva BS, Arnold ME, Zeng J, Dodge RW.
    J Immunol Methods; 2015 Jan; 416():94-104. PubMed ID: 25445325
    [Abstract] [Full Text] [Related]

  • 3. Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing.
    Xu W, Sank M, Cummings J, Carl S, Juhel M, Gleason C, Dodge R, DeSilva BS, Kolaitis G, Pillutla R.
    J Immunol Methods; 2018 Nov; 462():34-41. PubMed ID: 30099014
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Innovative use of LC-MS/MS for simultaneous quantitation of neutralizing antibody, residual drug, and human immunoglobulin G in immunogenicity assay development.
    Jiang H, Xu W, Titsch CA, Furlong MT, Dodge R, Voronin K, Allentoff A, Zeng J, Aubry AF, DeSilva BS, Arnold ME.
    Anal Chem; 2014 Mar 04; 86(5):2673-80. PubMed ID: 24506335
    [Abstract] [Full Text] [Related]

  • 6. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.
    Zoghbi J, Xu Y, Grabert R, Theobald V, Richards S.
    J Immunol Methods; 2015 Nov 04; 426():62-9. PubMed ID: 26255760
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of a method that eliminates false-positive results due to nerve growth factor interference in the assessment of fulranumab immunogenicity.
    Dai S, Schantz A, Clements-Egan A, Cannon M, Shankar G.
    AAPS J; 2014 May 04; 16(3):464-77. PubMed ID: 24590506
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox.
    Schneider AK, Vainshtein I, Roskos LK, Chavez C, Sun B, Liang M.
    J Immunol Methods; 2016 Aug 04; 435():68-76. PubMed ID: 27220271
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and validation of a cell based assay for the detection of neutralizing antibodies against recombinant insulins.
    Chatterjee S, Vashishta L, Waichale VS, Nayak VG, Melarkode R, Donnelly CM, Vallano PT, Chirmule N, Sengupta N.
    J Immunol Methods; 2018 Jan 04; 452():53-62. PubMed ID: 28935478
    [Abstract] [Full Text] [Related]

  • 14. Approaches to Resolve False Reporting in Neutralizing Antibody Assays Caused by Reagent Leaching from Affinity Capture Elution Solid Phase.
    Xiang Y, Kamerud J, Donley J, Olson K, Caiazzo T, Yeung D, Parng C, Gorovits B.
    AAPS J; 2018 Nov 06; 21(1):4. PubMed ID: 30402825
    [Abstract] [Full Text] [Related]

  • 15. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
    Smith HW, Butterfield A, Sun D.
    Regul Toxicol Pharmacol; 2007 Dec 06; 49(3):230-7. PubMed ID: 17869396
    [Abstract] [Full Text] [Related]

  • 16. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
    Qiu ZJ, Ying Y, Fox M, Peng K, Lewin-Koh SC, Coleman D, Good J, Lowe J, Rahman A, Yang J, Jiang J, Quarmby V, Song A.
    J Immunol Methods; 2010 Oct 31; 362(1-2):101-11. PubMed ID: 20868690
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.